Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Photography | 2 | 2024 | 40 | 1.580 |
Why?
|
| Dermatology | 3 | 2024 | 74 | 1.150 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 165 | 0.790 |
Why?
|
| Keratoacanthoma | 1 | 2020 | 2 | 0.670 |
Why?
|
| Drug Eruptions | 1 | 2020 | 15 | 0.660 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 47 | 0.630 |
Why?
|
| Telemedicine | 1 | 2024 | 327 | 0.610 |
Why?
|
| Skin | 1 | 2021 | 374 | 0.580 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 172 | 0.580 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2006 | 79 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 424 | 0.210 |
Why?
|
| Skin Diseases | 1 | 2024 | 82 | 0.200 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 489 | 0.190 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 688 | 0.180 |
Why?
|
| Medicine | 1 | 2022 | 57 | 0.180 |
Why?
|
| Quality Improvement | 2 | 2022 | 444 | 0.170 |
Why?
|
| Biopsy | 1 | 2021 | 444 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 59 | 0.160 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 57 | 0.160 |
Why?
|
| Immunotherapy | 1 | 2020 | 256 | 0.140 |
Why?
|
| Itraconazole | 1 | 2014 | 13 | 0.110 |
Why?
|
| Humans | 6 | 2024 | 63511 | 0.100 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2014 | 67 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2020 | 5699 | 0.090 |
Why?
|
| Patient Safety | 2 | 2022 | 244 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 412 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 663 | 0.070 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 37 | 0.060 |
Why?
|
| Genes, Insect | 1 | 2006 | 90 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2006 | 133 | 0.060 |
Why?
|
| Aged | 2 | 2020 | 14472 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 293 | 0.060 |
Why?
|
| Neuromuscular Junction | 1 | 2006 | 77 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 290 | 0.060 |
Why?
|
| Alleles | 1 | 2006 | 448 | 0.060 |
Why?
|
| Synapses | 1 | 2006 | 184 | 0.060 |
Why?
|
| Base Sequence | 1 | 2006 | 1331 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 642 | 0.050 |
Why?
|
| Phenotype | 1 | 2006 | 1207 | 0.050 |
Why?
|
| Male | 2 | 2020 | 29927 | 0.040 |
Why?
|
| Female | 2 | 2020 | 32912 | 0.040 |
Why?
|
| Safety Management | 1 | 2022 | 137 | 0.040 |
Why?
|
| Curriculum | 1 | 2022 | 600 | 0.030 |
Why?
|
| Chile | 1 | 2014 | 14 | 0.030 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 37 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 69 | 0.030 |
Why?
|
| Remission Induction | 1 | 2014 | 148 | 0.030 |
Why?
|
| California | 1 | 2014 | 174 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 299 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2014 | 369 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 508 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 988 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1173 | 0.020 |
Why?
|
| Animals | 1 | 2006 | 20666 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1537 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 3770 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1513 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 5474 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 17644 | 0.010 |
Why?
|